Macusoft
Macusoft is a healthcare technology company specializing in artificial intelligence (AI) clinical decision support systems for ophthalmology. Their cloud-based AI solutions optimize the management of preventable sight-threatening eye diseases by tailoring treatment to individual patients at the point-of-care. Macusoft's products, including MacuSense, FluoreSense, and RetinaSense, leverage genomic, clinical, and imaging data to improve diagnosis, treatment recommendations, and screening for conditions like macular disease and diabetic retinopathy. The company aims to reduce unnecessary sight loss globally by enabling scalable deployment across health systems, addressing the growing demand driven by aging populations and diabetes. Macusoft has gained traction through partnerships with organizations like Novartis UK and participation in accelerators such as DigitalHealth.London and KQ Labs, supporting NHS adoption and global impact, including initiatives in rural India.
Macusoft
Macusoft is a healthcare technology company specializing in artificial intelligence (AI) clinical decision support systems for ophthalmology. Their cloud-based AI solutions optimize the management of preventable sight-threatening eye diseases by tailoring treatment to individual patients at the point-of-care. Macusoft's products, including MacuSense, FluoreSense, and RetinaSense, leverage genomic, clinical, and imaging data to improve diagnosis, treatment recommendations, and screening for conditions like macular disease and diabetic retinopathy. The company aims to reduce unnecessary sight loss globally by enabling scalable deployment across health systems, addressing the growing demand driven by aging populations and diabetes. Macusoft has gained traction through partnerships with organizations like Novartis UK and participation in accelerators such as DigitalHealth.London and KQ Labs, supporting NHS adoption and global impact, including initiatives in rural India.